Ryan Reyes

CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATP-competitive mTOR inhibitor INK128

Thomas D. Schmittgen, S. Jacob, Jinmai Jiang, 2018, Oncotarget.

Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma

Philip R. O. Payne, Peng Hu, K. Ghoshal, 2020, Cancers.

Sorafenib and 2-Deoxyglucose Synergistically Inhibit Proliferation of Both Sorafenib-Sensitive and -Resistant HCC Cells by Inhibiting ATP Production.

K. Ghoshal, S. Jacob, Tasneem Motiwala, 2017, Gene expression.

Regulation of glucose metabolism in hepatocarcinogenesis by microRNAs.

S. Jacob, Tasneem Motiwala, Ryan Reyes, 2014, Gene expression.

The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer

K. Ghoshal, S. Jacob, Juan M. Barajas, 2018, Scientific Reports.

The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer

K. Ghoshal, S. Jacob, Juan M. Barajas, 2018, Scientific Reports.

miR-23a: A Key Metabolic Regulator in Hepatocellular Carcinoma Undergraduate Honors Thesis

Ryan Reyes, 2014 .